FDA considers approval of self-injectable flu vaccine

SGGP 10/27/2023 05:55

According to CNN, the US Food and Drug Administration (FDA) said it is considering approving a flu vaccine that can be self-injected at home because vaccination rates in 2023 remain low.

Earlier, AstraZeneca Pharmaceutical Group announced that its own nasal spray flu vaccine has been accepted for review by the FDA for approval. If approved, this will be the first self-injectable flu vaccine available in the US.

AstraZeneca said the nasal spray vaccine was produced based on research on the ability of people over 18 years old to self-inject the vaccine or to inject people between the ages of 2 and 49. The vaccine has also been tested to prove its effectiveness and safety comparable to other flu vaccines.

Statistics from the US Centers for Disease Control and Prevention (CDC) show that only 47% of adults in this country will get vaccinated against flu in 2022-2023, down from 49% in 2021-2022.

Source: https://www.sggp.org.vn/fda-xem-xet-phe-duyet-vaccine-phong-cum-tu-tiem-post711546.html